Related Experiment Video
Updated: Jul 23, 2026
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Published on: July 5, 2019
Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models
Kathrin B Labrosse1, Flavio C Lombardo2, Natalie Rimmer2
1Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland; Hospital for Women, University Hospital Basel, 4031 Basel, Switzerland.
None:
Three-dimensional (3D) ex vivo cultures allow the study of cancer progression and drug resistance mechanisms. Here, we present a protocol for measuring on-target drug sensitivity in a scaffold-free 3D culture system through quantification of apoptotic tumor cells. We provide detailed steps for sample processing, immunofluorescence staining, semi-high-throughput confocal imaging, and imaged-based quantification of 3D cultures. This protocol is versatile and can be applied in principle to any patient-derived material.
